Literature DB >> 2140807

Impairment of autologous mixed lymphocyte reaction in the spleen and peripheral blood lymphocytes of patients with idiopathic portal hypertension.

H Yamaue1, H Tanimura, M Iwahashi, T Tsunoda, M Tani, M Tamai, M Inoue.   

Abstract

The etiology of idiopathic portal hypertension (IPH) is unknown, although many studies have suggested that it might be an autoimmune disease. The autologous mixed lymphocyte reaction (AMLR) involves the proliferation of T lymphocytes when co-cultured with autologous non-T cells and may reflect immune control mechanisms in vivo. The AMLRs in the spleen and peripheral blood of three patients with IPH were measured and it was shown that the AMLRs both in the spleen and peripheral blood were significantly suppressed compared to those of normal healthy subjects. By allogeneic MLR, there was a tendency that the disturbance of non-T cells was more intensive than that of T cells. The AMLR of peripheral blood did not improve by splenectomy. Thus, the depressed cause of AMLR in patients with IPH was suggested mainly to disturbance of the antigen-presenting ability of non-T cells, and it was suggested that not only the spleen cells, but systemic immune disturbance caused the impairment of AMLR in IPH.

Entities:  

Mesh:

Year:  1990        PMID: 2140807     DOI: 10.1007/bf02776815

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  36 in total

1.  Defective autologous mixed leukocyte reaction in newly diagnosed type 1 diabetes mellitus.

Authors:  L Räsänen; H Hyöty; M Lehto; O P Kallioniemi; J Antonen; T Huupponen; J Karjalainen; P Leinikki
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

2.  T cells from patients with chronic liver diseases: abnormalities in PHA-induced expression of HLA class II antigens and in autologous mixed-lymphocyte reactions.

Authors:  M Scudeletti; F Indiveri; I Pierri; A Picciotto; S Ferrone
Journal:  Cell Immunol       Date:  1986-10-01       Impact factor: 4.868

3.  "Idiopathic" portal hypertension due to occlusion of intrahepatic portal veins by organized thrombi. A study based on postmortem vinylite-injection corrosion and dissection of the intrahepatic vasculature in 4 cases.

Authors:  J L Boyer; M R Hales; G Klatskin
Journal:  Medicine (Baltimore)       Date:  1974-01       Impact factor: 1.889

4.  Peripheral blood monocytes in the autologous mixed lymphocyte reaction.

Authors:  N L Dock; F R Davey
Journal:  Clin Immunol Immunopathol       Date:  1980-09

5.  The impaired ability of human monocytes to stimulate autologous and allogeneic mixed lymphocyte reactions after exposure to cyclosporine. Associated alterations of HLA-DR expression and physical characteristics of monocytes.

Authors:  R L Whisler; J A Lindsey; K V Proctor; Y G Newhouse; D G Cornwell
Journal:  Transplantation       Date:  1985-07       Impact factor: 4.939

6.  Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect.

Authors:  E G Engleman; C J Benike; R T Hoppe; H S Kaplan; F R Berberich
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

7.  Defect of autologous mixed lymphocyte reaction and interleukin-2 in aged individuals.

Authors:  G W Canonica; G Ciprandi; M Caria; W Dirienzo; A Shums; B Norton-Koger; H H Fudenberg
Journal:  Mech Ageing Dev       Date:  1985-11       Impact factor: 5.432

8.  Human T lymphocytes in aging and malignancy: abnormalities in PHA-induced Ia antigen expression and in functional activity in autologous and allogeneic MLR.

Authors:  F Indiveri; I Pierri; D Viglione; D Pende; C Russo; M A Pellegrino; S Ferrone
Journal:  Cell Immunol       Date:  1983-03       Impact factor: 4.868

9.  Decreased autologous mixed lymphocyte reaction in myasthenia gravis.

Authors:  I Richards; R Harrison; G G Lunt; J G Bowen
Journal:  J Clin Lab Immunol       Date:  1986-05

10.  Production of a cytokine with interleukin 3-like properties and cytokine-dependent proliferation in human autologous mixed lymphocyte reaction.

Authors:  R Suzuki; S Suzuki; T Takahashi; K Kumagai
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

View more
  3 in total

1.  Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment.

Authors:  Shiv Kumar Sarin; Ashish Kumar; Yogesh Kumar Chawla; Sanjay Saran Baijal; Radha Krishna Dhiman; Wasim Jafri; Laurentius A Lesmana; Debendranath Guha Mazumder; Masao Omata; Huma Qureshi; Rizvi Moattar Raza; Peush Sahni; Puja Sakhuja; Mohammad Salih; Amal Santra; Barjesh Chander Sharma; Praveen Sharma; Gamal Shiha; Jose Sollano
Journal:  Hepatol Int       Date:  2007-09-11       Impact factor: 6.047

2.  Idiopathic portal hypertension associated with high serum titer of autoantibodies and liver dysfunction.

Authors:  K Mori; E Ishimura; H Goto; S Shoji; S Seki; T Yamashita; K Wakasa; Y Nishizawa; H Morii
Journal:  J Gastroenterol       Date:  1996-02       Impact factor: 7.527

3.  "Endemic" idiopathic portal hypertension: report on 32 patients with non-cirrhotic portal fibrosis.

Authors:  C Vakili; M J Farahvash; T E Bynum
Journal:  World J Surg       Date:  1992 Jan-Feb       Impact factor: 3.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.